127 related articles for article (PubMed ID: 38185867)
1. Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy.
Poornachitra P; Muthukrishnan A; Devaraj E
Indian J Cancer; 2023 Oct; 60(4):595-596. PubMed ID: 38185867
[No Abstract] [Full Text] [Related]
2. Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.
Li CX; Gong ZC; Tan XR
Cancer Immunol Immunother; 2023 Sep; 72(9):3133-3134. PubMed ID: 37149552
[No Abstract] [Full Text] [Related]
3. Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).
Sivaperumal P; Sekaran S; Kamala K; Ganapathy D
Oral Oncol; 2022 Aug; 131():105971. PubMed ID: 35716647
[No Abstract] [Full Text] [Related]
4. MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
Selvakumar SC; K Auxzilia P; Dinesh Y; Senthilmurugan M; Sekar D
Oral Oncol; 2022 Jul; 130():105925. PubMed ID: 35606273
[No Abstract] [Full Text] [Related]
5. Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.
Jayaseelan VP; Paramasivam A
Future Oncol; 2022 Aug; 18(25):2767-2769. PubMed ID: 35766123
[No Abstract] [Full Text] [Related]
6. Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Muggia F
Oncologist; 2013; 18(3):245-7. PubMed ID: 23485623
[TBL] [Abstract][Full Text] [Related]
7. Engineered Dex: A promising therapeutic strategy for oral squamous cell carcinoma.
Vijayashree Priyadharsini J; Abilasha R; Anitha P; Paramasivam A
J Stomatol Oral Maxillofac Surg; 2023 Feb; 124(1):101277. PubMed ID: 36058533
[No Abstract] [Full Text] [Related]
8. Mitophagy: A therapeutic target for oral squamous cell carcinoma.
Balachander K; Paramasivam A
Oral Oncol; 2022 Jun; 129():105881. PubMed ID: 35504127
[No Abstract] [Full Text] [Related]
9. Electrochemotherapy as an Effective Alternative in the Treatment of Local Advanced Oral Squamous Cell Carcinoma: A Retrospective Analysis of Treated Cases.
Barca I; Ferragina F; Kallaverja E; Arrotta A; Cristofaro MG
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36982078
[TBL] [Abstract][Full Text] [Related]
10. Novel HSP90 inhibitor NVP-AUY922 enhances the anti-tumor effect of temsirolimus against oral squamous cell carcinoma.
Okui T; Shimo T; Fukazawa T; Mohammad Monsur Hassan N; Honami T; Ibaragi S; Takaoka M; Naomoto Y; Sasaki A
Curr Cancer Drug Targets; 2013 Mar; 13(3):289-99. PubMed ID: 23016912
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic nature of microRNAs in Oral Squamous Cell Carcinoma (OSCC).
Sekar D; Selvakumar SC; Auxzilia Preethi K
Oral Oncol; 2022 Nov; 134():106106. PubMed ID: 36067592
[No Abstract] [Full Text] [Related]
12. Novel therapeutic inhibitors for oral squamous cell cancer (OSCC) from seaweeds.
Kannan K; Pitchiah S; E D; Ramasamy P
Eur J Surg Oncol; 2023 May; 49(5):1048-1049. PubMed ID: 36702714
[No Abstract] [Full Text] [Related]
13. Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.
Liu J; Zhao J; Qiao X
Endocrinology; 2023 Sep; 164(11):. PubMed ID: 37738154
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TUG1 promotes proliferation, migration and cisplatin resistance in oral squamous cell carcinoma.
Liu S; Wang W; Ye L; Liu C; Xiao W; Gao J
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(8):1323-1326. PubMed ID: 37232574
[No Abstract] [Full Text] [Related]
15. Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
Jayaseelan VP; A S SG; Arumugam P
Oral Oncol; 2022 Jul; 130():105874. PubMed ID: 35533508
[No Abstract] [Full Text] [Related]
16. Paraoxonase-2 expression in oral squamous cell carcinoma.
Campagna R; Pozzi V; Salvucci A; Togni L; Mascitti M; Sartini D; Salvolini E; Santarelli A; Lo Muzio L; Emanuelli M
Hum Cell; 2023 May; 36(3):1211-1213. PubMed ID: 36774414
[No Abstract] [Full Text] [Related]
17. Early Discovery, Early Recovery: The principle behind successful oral squamous cell carcinoma treatment!
Misra SR; Das R
Oral Oncol; 2023 Oct; 145():106511. PubMed ID: 37478573
[No Abstract] [Full Text] [Related]
18. RET protein is overexpressed in oral squamous cell carcinoma.
Koole K; Peeters T; van Hengel OR; Brinkhuis A; van Es RJ; Willems SM
Histopathology; 2016 Dec; 69(6):1085-1087. PubMed ID: 27344057
[No Abstract] [Full Text] [Related]
19. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
20. A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.
Alhazzazi TY; Kamarajan P; Xu Y; Ai T; Chen L; Verdin E; Kapila YL
Anticancer Res; 2016 Jan; 36(1):49-60. PubMed ID: 26722027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
